Latest Articles

Open Access
SLFN12 Over-expression Sensitizes Triple Negative Breast Cancer Cells to Chemotherapy Drugs and Radiotherapy
AHMED ADHAM RAAFAT ELSAYED, SARMAD AL-MARSOUMMI, EMILIE E. VOMHOF-DEKREY and MARC D. BASSON

Cancer Genomics & Proteomics May 2022, 19 (3) 328-338; DOI: https://doi.org/10.21873/cgp.20323
Open Access
Role of Genetic Variations in CDK2, CCNE1 and p27^KIP1 in Prostate Cancer
MÁRK HÍVEŠ, JANA JUREČEKOVÁ, JÁN KLIMENT, MARIÁN GRENDÁR, PETER KAPLÁN, RÓBERT DUŠENKA, DANIEL EVIN, MARTA VILČKOVÁ, KLAUDIA HÍVEŠ HOLEČKOVÁ and MONIKA KMEŤOVÁ SIVOŇOVÁ

Cancer Genomics & Proteomics May 2022, 19 (3) 362-371; DOI: https://doi.org/10.21873/cgp.20326
Open Access
Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts
ANNA SANCHEZ, FRÉDÉRIQUE PENAULT-LLORCA, YVES-JEAN BIGNON, LAURENT GUY and DOMINIQUE BERNARD-GALLON

Cancer Genomics & Proteomics May 2022, 19 (3) 339-349; DOI: https://doi.org/10.21873/cgp.20324
Open Access
Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma
ULRICH H. WEIDLE, TATJANA SELA, ULRICH BRINKMANN and JENS NIEWOEHNER

Cancer Genomics & Proteomics May 2022, 19 (3) 283-298; DOI: https://doi.org/10.21873/cgp.20320
Open Access
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions
MICHELE MASSIMINO, STEFANIA STELLA, GIOVANNI MICALE, LUCIA MOTTA, GIULIANA PAVONE, GIUSEPPE BROGGI, ELIANA PIOMBINO, GAETANO MAGRO, HECTOR JOSE SOTO PARRA, LIVIA MANZELLA and PAOLO VIGNERI

Cancer Genomics & Proteomics May 2022, 19 (3) 350-361; DOI: https://doi.org/10.21873/cgp.20325
Open Access
Prognostic Relevance of ZNF844 and Chr 19p13.2 KRAB-Zinc Finger Proteins in Clear Cell Renal Carcinoma
SIMONE O. HEYLIGER, KARAM F.A. SOLIMAN, MARILYN D. SAULSBURY and R. RENEE REAMS

Cancer Genomics & Proteomics May 2022, 19 (3) 305-327; DOI: https://doi.org/10.21873/cgp.20322
Open Access
Deletion of MTAP Highly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant Methioninase
YUSUKE AOKI, YASUNORI TOME, QINGHONG HAN, JUN YAMAMOTO, KAZUYUKI HAMADA, NORIYUKI MASAKI, YUTARO KUBOTA, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Cancer Genomics & Proteomics May 2022, 19 (3) 299-304; DOI: https://doi.org/10.21873/cgp.20321
You have access
Combination of Circulating Tumour DNA and ¹⁸F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study
ONDREJ FIALA, JAN BAXA, MARTIN SVATON, LUCIE BENESOVA, RENATA PTACKOVA, TEREZA HALKOVA, MAREK MINARIK, PETR HOSEK, MARCELA BURESOVA, JINDRICH FINEK, JIRI FERDA and MILOS PESEK

Cancer Genomics & Proteomics March 2022, 19 (2) 270-281; DOI: https://doi.org/10.21873/cgp.20319
You have access
Mapping Proteome Changes in Microsatellite Stable, Recurrent Colon Cancer Reveals a Significant Immune System Signature
MAGNUS BERLE, KJERSTI E. HESTETUN, HEIDRUN VETHE, SIMONA CHERA, JOAO A. PAULO, OLAV DAHL and METTE PERNILLE MYKLEBUST

Cancer Genomics & Proteomics March 2022, 19 (2) 130-144; DOI: https://doi.org/10.21873/cgp.20309
You have access
MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer
METTE PERNILLE MYKLEBUST, ANNE METTE SØVIKNES, OLE JOHAN HALVORSEN, ANNA THOR, OLAV DAHL and HELGE RÆDER

Cancer Genomics & Proteomics March 2022, 19 (2) 178-193; DOI: https://doi.org/10.21873/cgp.20313

Main menu

User menu

Search

Latest Articles

Pages